Quick Facts

• Relief of cough
• Addresses symptoms associated with acute bronchitis and chronic obstructive pulmonary disease (COPD)
• Used in the management of chest congestion
• Helps to loosen thick mucus

---

Management of Cough and Respiratory Congestion

Ascoril Plus Syrup is a combination product used to help with the symptomatic relief of productive cough. This is a cough that involves the expulsion of mucus (phlegm) from the respiratory tract. The medicine is primarily utilized to alleviate symptoms related to various respiratory conditions.

Its key uses include providing relief in cases of acute and chronic bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). The syrup works to reduce the viscosity of secretions, making the mucus easier to expel, which can help to clear the airways and improve breathing.

Eligibility: Who Can and Cannot Use Ascoril Plus Syrup

This syrup's eligibility profile is strictly defined by regulatory documents based on age, pre-existing conditions, and physiological status.

Absolute Contraindications (Must Not Use)

The medicine is contraindicated and must not be used by individuals with known hypersensitivity to any of its active components (Bromhexine, Guaifenesin, Terbutaline, Menthol). Use is also prohibited in patients with certain severe, uncontrolled cardiac conditions (e.g., tachyarrhythmias, ischemic heart disease), severe thyrotoxicosis (uncontrolled hyperthyroidism), and decompensated diabetes mellitus. Additionally, it is contraindicated for patients with active gastric or duodenal ulcers and for those with glaucoma.

Age and Physiological Restrictions

Ascoril Plus Syrup is contraindicated in children under 2 years of age, and its use is not recommended in children under 6 years of age. It is also strictly contraindicated during both pregnancy and lactation.

Conditional Use (Use with Caution)

Patients with severe hepatic or renal impairment (liver or kidney disease), a history of peptic ulcers, or existing hypertension must use the medicine only with caution and under explicit medical supervision, as stated in official labeling.

Interactions with other medicines and products

Official regulatory documentation defines specific interaction patterns for the components of Ascoril Plus Syrup, primarily relating to the β2-agonist, Terbutaline.

Certain combinations are not recommended or require extreme caution due to Pharmacodynamic Reinforcement. This includes Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs), which may potentiate the vascular action of Terbutaline. Co-administration with Non-selective Beta-blockers (e.g., Propranolol) is not normally administered due to antagonism of the bronchodilator effect. Similarly, combining the syrup with other Sympathomimetic Agents is not recommended due to potentially deleterious cardiovascular effects.

Interaction with clearance is documented, as Terbutaline reduces serum Theophylline concentrations by increasing its systemic clearance. Conversely, the Bromhexine component promotes the penetration of certain Antibiotics (e.g., Erythromycin, Cephalexin) into pulmonary tissue.

Timing separation is mandated for specific contexts: caution is advised if Terbutaline is administered within two weeks of discontinuing an MAOI. The Guaifenesin component may cause interference with colorimetric urinary lab tests, requiring caution if urine is collected within 24 hours of a dose. Consumption of alcohol may also enhance certain central nervous system side effects such as drowsiness.

The active components modulate physiological processes within the respiratory system, targeting both muscle tone and the physical properties of secretions.

beta2-Adrenergic Receptor Modulation and Smooth Muscle Relaxation

This domain covers the action of Terbutaline as a selective agonist of beta2-adrenergic receptors (beta2-AR) on the smooth muscles of the airways. Activation of the beta2-AR initiates an intracellular signaling cascade that ultimately leads to a decrease in the concentration of free intracellular calcium ( Ca^2+), resulting in the relaxation of constricted muscles and the resultant widening of the air passages (bronchodilation).

Mucus Structure and Secretion Modulation

This key mechanism involves the direct alteration of phlegm consistency and the stimulation of fluid output. Bromhexine acts as a mucolytic to chemically depolymerize acid mucopolysaccharide fibers, reducing the stiffness of mucus. Concurrently, Guaifenesin triggers a vagal reflex via the stomach, leading to a significant increase in the volume of watery respiratory fluid. This combined action ensures the secretions exhibit lower viscosity and elasticity, accelerating the natural mucociliary clearance process.

Sensory Nerve Ending and Reflex Arc Modulation

This action includes Menthol's local effect, which activates Transient Receptor Potential Melastatin 8 ( TRPM8) cold receptors on sensory nerves to reflexively modulate the central cough generation mechanism. The bronchodilation of the airways mechanically improves the pathway for the expulsion of the now-thinned and copious secretions, contributing to the overall efficiency of the clearance mechanism.

Ascoril Plus is a combination oral liquid designed for administration by the oral route (by mouth). Standard usage patterns are established for this medicine to ensure the proper intake of the combination of bromhexine, guaifenesin, terbutaline, and menthol.

---

Administration and Dosage Schedules

Before administration, the bottle must be shaken well to ensure the uniform suspension of the active ingredients. The correct volume must be measured precisely using the measuring cup or spoon provided. The medicine is typically administered on a three-times-daily (TID) schedule.

Age Group	Standard Volume Dose (TID)
Adults and Adolescents (12 years and older)	10 mL
Children (6 to 12 years)	5 mL to 10 mL
Children (2 to 6 years)	2.5 mL to 5 mL

Adult and pediatric dosing regimens are established for the management of symptoms.

---

Procedural Rules and Duration

The dose must not exceed four administrations in any 24-hour period, a rule associated with the Terbutaline component.

The medicine may be consumed with or without food. If a dose is missed, it should be taken as soon as remembered, unless it is near the time for the next dose; in this case, the missed dose must be skipped as doubling the dose is not permitted. Use of the syrup is intended to be short-term for symptomatic relief; medical advice must be sought if the condition persists for longer than seven days.

Ascoril Plus Syrup: Recent Clinical Evidence

Clinical evidence for Ascoril Plus Syrup primarily focuses on the combined actions of its components in managing productive cough associated with various respiratory disorders, such as bronchitis and acute respiratory tract infections (ARVI).

Acute Symptom Relief

Studies have assessed the effectiveness of the fixed combination in promoting the clearance of respiratory secretions. Clinical trials have explored the relief of symptoms related to the presence of thick mucus in the airways. Primary outcomes often evaluated include the patient-reported severity of cough, the characteristics of sputum (mucus), and breathlessness.

• Trial Design: Multiple studies, including randomized double-blind comparative trials and international multicenter non-interventional studies, have investigated the formulation in both adult and pediatric patients.
• Observed Response: In some cohorts, a reduction in the intensity of cough was noted shortly after initiating the treatment.

---

Tolerability and Safety Monitoring

Research has concentrated on monitoring the overall tolerability of the combination, particularly concerning common side effects. Safety assessments focus on the specific known effects of the ingredients:

• Cardiovascular Monitoring: Studies have examined the effect of the treatment's bronchodilator component on the heart rate of patients, particularly in individuals with pre-existing heart conditions.
• Hypersensitivity: The adverse reaction profile is carefully monitored for signs of allergic responses or severe skin reactions, though these are reported as rare.
• Long-Term Use: Data collection involves observing adverse events to assess overall safety in both children and adults over the treatment period. Tolerability is often assessed by tracking the rate at which participants discontinued the treatment.

Common questions about Ascoril Plus Syrup (FAQ)

Q: Is Ascoril Plus Syrup primarily for a dry cough or a wet cough?

The official regulatory indication for this fixed-dose combination is the relief of symptoms related to a productive cough (wet cough) and excessive chest congestion. The ingredients are designed to help break up and thin mucus, facilitating its clearance from the airways.

Q: How quickly does Ascoril Plus Syrup usually start working?

According to information available in patient labeling, the medicine often begins to exert its effects within a few minutes after administration. This rapid action is mainly associated with the bronchodilator component, which works quickly to open the air passages.

Q: How long do the effects of Ascoril Plus Syrup typically last?

The duration of action is usually described in patient information as lasting up to several hours. This length of time is consistent with the general recommendation for administering the syrup according to a three-times-daily schedule.

Q: Can I take Ascoril Plus Syrup if I have a history of heart problems?

Regulatory documents advise that individuals with pre-existing cardiovascular diseases or a history of heart issues should use the medicine with caution. The bronchodilator component ( Terbutaline) can affect heart function, and the official document advises that patients use the medicine under the guidance of a healthcare professional.

Q: Can Ascoril Plus Syrup be taken by individuals with diabetes?

The medicine is contraindicated for patients with decompensated diabetes mellitus (uncontrolled or unstable diabetes). For other diabetic patients, official warnings indicate the beta2-agonist ingredient can potentially increase blood glucose levels, and monitoring blood glucose levels may be required.

Q: Should Ascoril Plus Syrup be taken with food or on an empty stomach?

Official product labeling states that Ascoril Plus Syrup may be consumed with or without food. There are no specific regulatory requirements for taking the medicine at a particular mealtime.

Q: Are there specific symptoms that mean I should stop taking Ascoril Plus Syrup?

Regulatory warnings describe symptoms of serious adverse effects that may require immediate medical attention, such as signs of a fast or irregular heart rate, or signs of a severe allergic response. Official guidelines also state that medical advice should be sought if the cough persists for longer than seven days.

Q: Is it common to feel drowsy after taking Ascoril Plus Syrup?

Drowsiness or sleepiness is documented in the regulatory adverse reaction profile as a common side effect of this medicine. This effect is listed in the product's safety information.

Q: Does Ascoril Plus Syrup affect blood pressure?

Caution is advised for patients with pre-existing hypertension (high blood pressure). The beta2-agonist component ( Terbutaline) may potentially influence blood pressure and cardiovascular function, and regulatory documents suggest monitoring is necessary in relevant patient groups.

Q: Is it possible to become dependent on Ascoril Plus Syrup?

The regulatory guidelines define the use of the syrup for short-term symptomatic relief only. Official documents outlining the composition and effects of the active ingredients do not list dependence as a characteristic of its intended brief use.

Q: Does Ascoril Plus Syrup affect sleep?

Official safety information indicates that the syrup may affect sleep patterns. The adverse reaction profile lists drowsiness as a common effect and also includes reports of sleep disturbances or insomnia.

Q: Why do some people report feeling nervous or restless after taking this syrup?

The presence of common adverse reactions like nervousness and tremor (shakiness) is associated with the mechanism of the bronchodilator ingredient, Terbutaline. This effect is due to the way this component interacts with the nervous system.

Q: Is the syrup generally well-tolerated?

Clinical data often report that the medicine is generally well-tolerated when taken according to the recommended usage guidelines. Official safety information notes that certain common effects, such as tremor, may be more pronounced when treatment is first initiated but can lessen over time.

Q: Can I use Ascoril Plus Syrup if I have thyroid issues?

The medicine is strictly contraindicated for use in patients with severe thyrotoxicosis (uncontrolled hyperthyroidism). For patients with other forms of thyroid disorders, regulatory warnings advise that the syrup is used under the guidance of a healthcare professional.

Q: Do studies show Ascoril Plus Syrup helping with shortness of breath related to cough?

Clinical studies have assessed the effect of the syrup on symptoms like breathlessness as part of its efficacy profile. The inclusion of a bronchodilator in the formulation is intended to widen constricted airways, which may contribute to easier breathing.

Q: Can Ascoril Plus Syrup be used for coughs caused by smoking?

Official labeling indicates that this type of cough medicine is not intended for the management of persistent or chronic cough, such as that experienced by smokers or individuals with conditions like emphysema. It is targeted toward acute, productive coughs.

Q: Does Ascoril Plus Syrup interact with herbal supplements?

Regulatory documents outline the potential need for consultation with a healthcare professional before combining the syrup with any herbal or natural supplements. This precaution is taken because of the potential for unforeseen interactions that could affect the safety or effectiveness of either substance.

Q: Can Ascoril Plus Syrup be used alongside asthma inhalers?

Co-administration with other Sympathomimetic Agents is generally not recommended. Because some asthma inhalers contain similar types of ingredients, combining them with the bronchodilator in Ascoril Plus Syrup could potentially increase the risk of side effects, particularly those affecting the heart.

Q: Does Ascoril Plus Syrup contain sugar?

The standard formulation of the syrup typically includes sugar among its base ingredients (excipients). Individuals who need to restrict sugar intake, such as those with diabetes, should note that information regarding sugar content is found on the product label.

Q: Does Ascoril Plus Syrup contain alcohol?

Official labeling indicates that some formulations of the syrup contain a small amount of alcohol in the base ingredients. Patients who are advised to avoid alcohol, such as those with liver disease, should note that information regarding alcohol content is found on the specific product label.

Q: Is it normal to have a dry mouth while using Ascoril Plus Syrup?

Dry mouth is listed in official regulatory documentation as a documented adverse effect associated with the use of the medicine. It is considered a possible reaction to the active components in the syrup.

Q: Are there any long-term effects associated with Ascoril Plus Syrup use?

The syrup is primarily intended for short-term symptomatic relief, and regulatory guidelines recommend against continuous use for longer than seven days. Consequently, official safety documents do not address a comprehensive profile of effects associated with use beyond this recommended short duration.

How to Store and Dispose of Ascoril Plus Syrup?

The storage and disposal of Ascoril Plus Syrup must adhere strictly to the conditions specified on the official product label.

Storage Requirements

The medicine is required to be stored below 30 C in a cool and dry place. It must be kept protected from light, heat, and moisture to maintain its stability up to the expiration date. To preserve the formulation, the syrup must be kept in the container it came in and sealed tightly closed after each use. A mandatory safety requirement is to store the product out of the reach and sight of children and pets.

Disposal Instructions

Expired or unused portions of the syrup must be disposed of according to local requirements. The labeling instructs users not to consume the medicine after the expiry date and to ensure the discarded product is not consumed by pets, children, or other people.